MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for Cell Viability Assays

Executive Summary: MTT, supplied by APExBIO (SKU B7777), is a high-purity tetrazolium salt extensively used in in vitro cell viability and metabolic activity assays [product]. It is reduced by cellular NADH-dependent oxidoreductases to insoluble formazan, offering a direct, quantitative measure of viable cells [1]. MTT’s cationic, membrane-permeable nature enables efficient cell penetration without the need for exogenous carriers [2]. It is soluble at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water (with sonication) [product]. The assay’s colorimetric readout is highly reproducible and compatible with high-throughput screening platforms [3].

Biological Rationale

Cell viability assays are fundamental to biomedical research, enabling quantification of living cells in response to various stimuli. MTT is the archetype tetrazolium salt for these applications due to its sensitivity and robust performance in colorimetric detection of metabolically active cells [4]. The reduction of MTT to formazan is catalyzed predominantly by mitochondrial NADH-dependent oxidoreductases, directly correlating with cellular metabolic activity [1]. High-throughput studies in cancer research, apoptosis, and drug screening routinely employ MTT to assess cytotoxicity and proliferation [5]. Its cationic nature distinguishes MTT from other tetrazolium salts, facilitating efficient uptake by intact, viable cells and yielding reliable data unaffected by extracellular reduction [2].

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT is a yellow, water-soluble tetrazolium salt (CAS 298-93-1). Upon entering viable cells, it is reduced primarily by mitochondrial NADH-dependent oxidoreductases, and to a lesser extent by extra-mitochondrial enzymes, to form insoluble purple formazan crystals [1]. This reaction is proportional to the number of metabolically active cells present. The formazan product accumulates intracellularly and requires solubilization (typically with DMSO or ethanol) for spectrophotometric quantification at 570 nm (±10 nm) [product]. The specificity of MTT for living cells arises because only cells with intact, functional metabolism can reduce the reagent. Non-viable or apoptotic cells lack this capability, resulting in minimal background signal [3].

Evidence & Benchmarks

• MTT reduction is directly proportional to viable cell number across multiple mammalian cell lines and conditions (Huan Chen et al., DOI:10.1038/s41467-022-35709-0).
• MTT demonstrates high sensitivity, detecting as few as 500–1,000 viable cells per well in 96-well plate formats (APExBIO product specifications, product).
• Formazan formation is NADH-dependent and correlates with mitochondrial function, enabling discrimination between cytostatic and cytotoxic effects (Chen et al., DOI:10.1038/s41467-022-35709-0).
• MTT’s cationic, membrane-permeable properties yield faster, more uniform cellular uptake compared to negatively charged tetrazolium salts (Cellron.com, internal).
• MTT-based assays are standard for evaluating anti-cancer drug efficacy, apoptosis induction, and immunotherapy responses (Colorimetric-Assay.com, internal).

Applications, Limits & Misconceptions

MTT is routinely applied in the following areas:

• Cancer Research: Quantifies cell proliferation and cytotoxicity in response to chemotherapeutics and targeted agents [1].
• Apoptosis Assays: Measures metabolic activity loss during programmed cell death [3].
• Drug Screening: Enables rapid, high-throughput assessment of compound libraries for cell viability effects [4].
• Metabolic Activity Measurement: Distinguishes between live, apoptotic, and necrotic states based on NADH-dependent reduction [5].

However, several boundaries exist. MTT reduction does not occur in cells lacking functional mitochondria or NADH pools. Some cell types exhibit variable formazan solubilization, affecting quantitative accuracy. Redox-active compounds in test media may artificially increase background signals. Cell density beyond the linear range (>2×10⁵ cells/well in 96-well plates) can saturate the assay. MTT is not suitable for in vivo applications or direct clinical diagnostics, as specified by APExBIO.

Common Pitfalls or Misconceptions

• MTT cannot distinguish between increased cell size and increased cell number; both can raise formazan output.
• Dead or late-apoptotic cells with residual metabolism may transiently reduce MTT, leading to overestimation of viability.
• Compounds with strong reducing potential may interfere, producing false-positive signals independent of cell viability.
• MTT is not membrane-impermeant; it can enter most eukaryotic cells, but not bacterial or yeast cells without permeabilization.
• MTT-based assays are endpoint measurements and do not allow real-time kinetic studies without repeated sampling.

For a deeper dive into the mechanistic aspects and troubleshooting, see this article (which details mechanistic advances), and this workflow review (which provides guidance for maximizing reproducibility). This article extends those by providing updated, benchmarked claims and clarifying current misconceptions in high-throughput contexts.

Workflow Integration & Parameters

MTT (B7777, APExBIO) is supplied as a powder with purity ≥98%. For use, it is dissolved at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, or ≥2.5 mg/mL in water (with ultrasonic assistance) [product]. Working concentrations typically range from 0.25–1.0 mg/mL in culture medium. Incubation at 37°C for 1–4 hours allows adequate formazan formation. After incubation, medium is carefully removed, and formazan is solubilized using DMSO or isopropanol. Absorbance is measured at 570 nm (reference 620–690 nm). For optimal stability, store MTT at -20°C; solutions are for short-term use only. Always use freshly prepared solutions for best reproducibility.

Compared to other tetrazolium salts (e.g., XTT, WST-1), MTT does not require external electron mediators and is less prone to extracellular reduction, which enhances signal specificity [2].

Conclusion & Outlook

MTT remains the gold standard for colorimetric cell viability and metabolic assays in vitro. Its direct, NADH-dependent reduction to formazan provides a robust, quantitative metric for living cells. APExBIO’s high-purity MTT (B7777) offers exceptional reproducibility and sensitivity, supporting applications in cancer research, apoptosis, and high-throughput drug screening. Researchers should rigorously control for known assay boundaries and interference to maximize data reliability. Future advances may combine MTT with real-time platforms or multiplexed readouts, but for endpoint viability, its utility remains unmatched.